The Stem Cell Therapeutic and Research Acts include two components:
The CWBYCTP operates through three major contracts. CWBYCTP awarded three contracts: the Single Point of Access-Coordinating Center (SPA-CC), the Stem Cell Therapeutic Outcomes Database (SCTOD) and the Office of Patient Advocacy (OPA). The SPA-CC contract is comprised of a merger of the Bone Marrow Coordinating Center (BMCC), Cord Blood Coordinating Center (CBCC), and Single Point of Access (SPA) functions. Prior to September 2017, the BMCC and CBCC functions operated as two separate contracts, whereas the SPA function operated conjointly with the OPA function as one contract.
The three CWBYCTP contracts work together to support the overall goals to:
The Stem Cell Therapeutic and Research Acts of 2005, 2010 and 2015 require the Secretary of the HHS to contract with qualified public cord blood banks to create a National Cord Blood Inventory (NCBI). Although the NCBI is a separate part of the CWBYCTP, its goals and requirements are closely aligned with the other CWBYCTP components and contractors. The NCBI’s goal is to collect at least 150,000 new cord blood units. These cord blood units must meet specific criteria and are made available for transplantation through the CWBYCTP.
For an overview of the NCBI requirements, see National Cord Blood Inventory Contract Summary.
Read more about the legislation that was passed by the United States Congress to help patients who need a bone marrow or umbilical cord blood transplant.